Advertisement
Advertisement
U.S. Markets open in 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

Boston Properties, Inc. (BXP)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
73.66-0.85 (-1.14%)
At close: 04:00PM EDT
73.01 -0.65 (-0.88%)
Pre-Market: 08:00AM EDT
Advertisement
Full screen
Loading interactive chart...
  • Zacks

    Boston Properties' (BXP) Buyout Boosts Life-Science Portfolio

    Boston Properties (BXP) acquires 125 Broadway in Kendall Square in Cambridge, MA, from Biogen for $592 million. The move aids its expansion efforts in the life sciences space in Cambridge.

  • American City Business Journals

    Biogen sells one Kendall Square building, ends lease on another

    Biogen Inc. has sold a six-floor lab building in Kendall Square to Boston Properties Inc. for $603 million and ended its lease early on a nearby office building, as part of its continued drive to shrink its real estate footprint.

  • Business Wire

    BXP Expands Life Sciences Portfolio in Kendall Square in Cambridge, MA

    BOSTON, September 20, 2022--BXP (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it completed the acquisition of 125 Broadway, a six-story, 271,000 square foot laboratory/life sciences property. BXP purchased the property from Biogen for a gross purchase price of approximately $592.0 million. Biogen has signed a lease for and will continue to occupy the entire property through April 2028. BXP funded the purcha

Advertisement
Advertisement